The challenge to diagnose and treat cognitive decline in our growing aging population is great. Alzheimer’s diagnosis in the US is predicted to soar (to 13.8 million in 2060, up from 6.2 million in 2021)—and so are nationwide shortages of specialists, including geriatricians and neurologists. This one-two punch puts pressure on primary care physicians (PCPs), […]
Read more